Construction of a drug, miRNA, and transcription factor regulatory network in membranous nephropathy based on oxidative stress-related genes

References

• Alsharhan L, Beck LH. Membranous nephropathy: core curriculum 2021. Am J Kidney Dis. 2021;77:440–453. doi:10.1053/j.ajkd.2020.10.009
   PubMed Web of Science ®Google Scholar
• Fan M, Lan X, Wang Q, et al. Renal function protection and the mechanism of ginsenosides: current progress and future perspectives. Front Pharmacol. 2023;14:1070738. doi:10.3389/fphar.2023.1070738
   PubMed Web of Science ®Google Scholar
• Xiao C, Liu Y, Zhang X, et al. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy. J Clin Lab Anal. 2020;34:e23368. doi:10.1002/jcla.23368
   PubMed Web of Science ®Google Scholar
• Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100:753–779. doi:10.1016/j.kint.2021.05.015
   PubMed Web of Science ®Google Scholar
• Piao M, Tu Y, Zhang N, et al. Advances in the application of phytogenic extracts as antioxidants and their potential mechanisms in ruminants. Antioxidants (Basel). 2023: 12.
   PubMedGoogle Scholar
• Murphy K, Llewellyn K, Wakser S, et al. Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system. J Biol Chem. 2018;293:18242–18269. doi:10.1074/jbc.RA117.001245
   PubMed Web of Science ®Google Scholar
• Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006;126:2565–2575. doi:10.1038/sj.jid.5700340
   PubMed Web of Science ®Google Scholar
• Chen F, Liu H, Wu J, et al. miR-125a suppresses TrxR1 expression and is involved in H2O2-induced oxidative stress in endothelial cells. J Immunol Res. 2018;2018:6140320.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41:D991–D9D5. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Wang S, Tian J, Wang J, et al. Identification of the biomarkers and pathological process of heterotopic ossification: weighted gene Co-expression network analysis. Front Endocrinol (Lausanne). 2020;11:581768. doi:10.3389/fendo.2020.581768
   PubMed Web of Science ®Google Scholar
• Pan Y, Wu L, He S, et al. Identification of hub genes and immune cell infiltration characteristics in chronic rhinosinusitis with nasal polyps: bioinformatics analysis and experimental validation. Front Mol Biosci. 2022;9:843580. doi:10.3389/fmolb.2022.843580
   PubMed Web of Science ®Google Scholar
• Yang G, Zeng C, Liu Y, et al. ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis. Am J Transl Res. 2021;13:5866–5879.
   PubMed Web of Science ®Google Scholar
• Li N, Li D, Du Y, et al. Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer. Oncol Rep. 2019;41:875–884.
   PubMed Web of Science ®Google Scholar
• Zhang B, He M. Identification of potential biomarkers for coronary artery disease based on cuproptosis. Cardiovasc Ther. 2023;2023:5996144.
   PubMed Web of Science ®Google Scholar
• Taleban S, Li D, Targan SR, et al. Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits. J Crohns Colitis. 2016;10:43–49. doi:10.1093/ecco-jcc/jjv178
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan A, Cao W, et al. Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma. Cancer Cell Int. 2020;20:584. doi:10.1186/s12935-020-01670-5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang W, Xia Q, et al. Construction of a potential microRNA and messenger RNA regulatory network of acute lung injury in mice. Sci Rep. 2022;12:777. doi:10.1038/s41598-022-04800-3
   PubMed Web of Science ®Google Scholar
• Wang J, Qin D, Ye L, et al. CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database. Aging (Albany NY). 2022;14:4158–4175. doi:10.18632/aging.204081
   PubMedGoogle Scholar
• Liu S, Wang W, Zhao Y, et al. Identification of potential key genes for pathogenesis and prognosis in prostate cancer by integrated analysis of gene expression profiles and the cancer genome atlas. Front Oncol. 2020;10:809. doi:10.3389/fonc.2020.00809
   PubMed Web of Science ®Google Scholar
• Ji X, Ma S, Sun X, et al. Analysis of ferroptosis-associated genes in Crohn’s disease based on bioinformatics. Front Med (Lausanne). 2022;9:1058076. doi:10.3389/fmed.2022.1058076
   PubMedGoogle Scholar
• Wu N, Liu F, Huang Y, et al. Necroptosis related genes predict prognosis and therapeutic potential in gastric cancer. Biomolecules. 2023: 13.
   PubMed Web of Science ®Google Scholar
• Ge X, Liu Z, Weng S, et al. Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma. Comput Struct Biotechnol J. 2022;20:3449–3460. doi:10.1016/j.csbj.2022.06.064
   PubMed Web of Science ®Google Scholar
• Beshnova D, Ye J, Onabolu O, et al. De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection. Sci Transl Med. 2020: 12.
   Web of Science ®Google Scholar
• Zhang J, Ding N, Xin W, et al. Quantitative proteomics reveals that a prognostic signature of the endometrium of the polycystic ovary syndrome women based on ferroptosis proteins. Front Endocrinol (Lausanne). 2022;13:871945. doi:10.3389/fendo.2022.871945
   PubMed Web of Science ®Google Scholar
• Hu Z, Liu Y, Yao Z, et al. Stages of preadipocyte differentiation: biomarkers and pathways for extracellular structural remodeling. Hereditas. 2022;159:47. doi:10.1186/s41065-022-00261-w
   PubMed Web of Science ®Google Scholar
• Ferreira WAS, Amorim CKN, Burbano RR, et al. Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1. Braz J Med Biol Res. 2021;54:e9571. doi:10.1590/1414-431x20209571
   PubMed Web of Science ®Google Scholar
• Kolur V, Vastrad B, Vastrad C, et al. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis. BMC Cardiovasc Disord. 2021;21:329. doi:10.1186/s12872-021-02146-8
   PubMed Web of Science ®Google Scholar
• Just J, Yan Y, Farup J, et al. Blood flow-restricted resistance exercise alters the surface profile, miRNA cargo and functional impact of circulating extracellular vesicles. Sci Rep. 2020;10:5835. doi:10.1038/s41598-020-62456-3
   PubMed Web of Science ®Google Scholar
• Gao J, Wei L, Song J, et al. In vitro and in vivo study of the expression of the Syk/Ras/c-Fos pathway in chronic glomerulonephritis. Mol Med Rep. 2018;18:3683–3690.
   PubMed Web of Science ®Google Scholar
• Mei H, Li L, Liu S, et al. The uniform-score gene set analysis for identifying common pathways associated with different diabetes traits. BMC Genomics. 2015;16:336. doi:10.1186/s12864-015-1515-3
   PubMed Web of Science ®Google Scholar
• Freedman BI, Hicks PJ, Bostrom MA, et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant. 2009;24:3366–3371. doi:10.1093/ndt/gfp316
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Liu G, et al. Antioxidant stress and anticancer activity of peptide-chelated selenium in vitro. Int J Mol Med. 2021: 48.
   PubMed Web of Science ®Google Scholar
• Leung C-H, Zhang J-T, Yang G-J, et al. Emerging screening approaches in the development of Nrf2-Keap1 protein-protein interaction inhibitors. Int J Mol Sci. 2019: 20.
   PubMed Web of Science ®Google Scholar
• Rush BM, Bondi CD, Stocker SD, et al. Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice. Kidney Int. 2021;99:102–116. doi:10.1016/j.kint.2020.07.036
   PubMed Web of Science ®Google Scholar
• Pessôa BS, Peixoto EBMI, Papadimitriou A, et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin Angiotensin Aldosterone Syst. 2012;13:56–66. doi:10.1177/1470320311422581
   PubMed Web of Science ®Google Scholar
• Shi H, Hou Y, Su X, et al. Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology. Ren Fail. 2022;44:116–125. doi:10.1080/0886022X.2021.2024850
   PubMed Web of Science ®Google Scholar